Nitroxyl increases force development in rat cardiac muscle

Journal of Physiology

Volumn 580, Issue 3, 2007, Pages 951-960

  Dai, Tieying ^a   Tian, Ye ^a,b   Tocchetti, Carlo Gabriele ^a   Katori, Tatsuo ^a   Murphy, Anne M ^a   Kass, David A ^a   Paolocci, Nazareno ^a,c   Gao, Wei Dong ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (MAGNESIUM); CALCIUM ION; DITHIOTHREITOL; FURA 2; MYOSIN ADENOSINE TRIPHOSPHATASE; NITRIC OXIDE; TEMPOL; 1,1 DIETHYL 2 HYDROXY 2 NITROSOHYDRAZINE; 1,1-DIETHYL-2-HYDROXY-2-NITROSOHYDRAZINE; ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); CALCIUM; HYDRAZINE DERIVATIVE; NITRIC OXIDE DONOR; NITRITE; NITROGEN OXIDE; NITROXYL; OXYHYPONITRITE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; CALCIUM SENSITIZER; CELL PROTEIN; CHEMICAL COMPOUND;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FORCE TRANSDUCER; HEART CONTRACTION; HEART MUSCLE CONTRACTILE FORCE; HEART RIGHT VENTRICLE; MUSCLE TWITCH; MYOFILAMENT; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PH; PRIORITY JOURNAL; RAT; ROOM TEMPERATURE; SARCOMERE LENGTH; STATISTICAL SIGNIFICANCE; STEADY STATE; ANIMAL; DRUG EFFECT; ENZYMOLOGY; HEART; HEART MUSCLE; IN VITRO STUDY; INTRACELLULAR MEMBRANE; METABOLISM; MUSCLE FIBRIL; OSMOLARITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ANIMAL CELL; CALCIUM TRANSPORT; HEART TRABECULAR MUSCLE; MUSCLE STRENGTH;

ANIMALS; CA(2+) MG(2+)-ATPASE; CALCIUM; HEART; HYDRAZINES; INTRACELLULAR MEMBRANES; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOFIBRILS; NITRIC OXIDE DONORS; NITRITES; NITROGEN OXIDES; OSMOLAR CONCENTRATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34249853701     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.129254     Document Type: Article

References (47)

1. 2+] in intact rat cardiac trabeculae. J General Physiol 105, 1-19.
2. Balligand JL (1999). Regulation of cardiac β-adrenergic response by nitric oxide. Cardiovasc Res 43, 607-620.
3. Brenner B (1984). The cross-bridge cycle in muscle. Mechanical, biochemical, and structural studies on single skinned rabbit fibers to characterize cross-bridge kinetics in muscle for correlation with the actomyosin-ATPase in solution. Basic Res Cardiol 81, 1-15.
4. Brenner B (1993). Changes in calcium sensitivity at the cross-bridge level. In Modulation of Cardiac Calcium Sensitivity: A New Approach to Increasing the Strength of the Heart, ed. Lee JA & Allen DG, pp. 197-214. Oxford University Press, Oxford.
5. Brunner F, Andrew P, Wolkart G, Zechner R & Mayer B (2001). Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104, 3097-3102.
6. Brunner F & Wolkart G (2003). Peroxynitrite-induced cardiac depression: Role of myofilament desensitization and cGMP pathway. Cardiovasc Res 60, 355-364.
7. Campbell K (1997). Rate constant of muscle force redevelopment reflects cooperative activation as well as cross-bridge kinetics. Biophys J 72, 254-262.
8. Canton M, Neverova I, Menabo R, Van Eyk J & Di Lisa F (2004). Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am J Physiol Heart Circ Physiol 286, H870-H877.
9. 2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37, 87-96.
10. Chesnais J-M, Fischmeister R & Méry P-F (1999). Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart. J Physiol 518, 449-461.
11. Fabiato A (1981). Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J General Physiol 78, 457-497.
12. Fukuto JM, Bartberger MD, Dutton AS, Paolocci N, Wink DA & Houk KN (2005). The physiological chemistry and biological activity of nitroxyl (HNO). The neglected, misunderstood, and enigmatic nitrogen oxide. Chem Res Toxicol 18, 790-801.
13. 2+ sensitivity in intact versus skinned rat ventricular muscle. Circ Res 74, 408-415.
14. 2+-dependent proteolysis? Circ Res 78, 455-465.
15. Gao WG, Liu Y & Marban E (1996 b). Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium. Circulation 94, 2597-2604.
16. Gao WG, Perez NG & Marban E (1998). Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol 507, 175-184.
17. Gross T, Lues I & Daut J (1993). A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle. J Mol Cell Cardiol 25, 239-244.
18. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J & Linden IB (1995). Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 27, 1859-1866.
19. Layland J, Li JM & Shah AM (2002). Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 540, 457-467.
20. Layland J, Solaro RJ & Shah AM (2005). Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res 66, 12-21.
21. Levijoki J, Pollesello P, Kaivola J, Tilgmann C, Sorsa T, Annila A, Kilpelainen I & Haikala H (2000). Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan. J Mol Cell Cardiol 32, 479-491.
22. Lopez BE, Rodriguez CE, Pribadi M, Cook NM, Shinyashiki M & Fukuto JM (2005). Inhibition of yeast glycolysis by nitroxyl (HNO): Mechanism of HNO toxicity and implications to HNO biology. Arch Biochem Biophys 442, 140-148.
23. Massion PB, Pelat M, Belge C & Balligand JL (2005). Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A Mol Integr Physiol 142, 144-150.
24. Miranda KM, Dutton AS, Ridnour LA, Foreman CA, Ford E, Paolocci N, Katori T, Tocchetti CG, Mancardi D, Thomas DD, Espey MG, Houk KN, Fukuto JM & Wink DA (2005). Mechanism of aerobic decomposition of Angeli's salt (sodium trioxodinitrate) at physiological pH. J Am Chem Soc 127, 722-731.
25. Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, Espey MG, Kass DA, Feelisch M, Fukuto JM & Wink DA (2003). A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci U S A 100, 9196-9201.
26. Murad F (1994). Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cyclic GMP signal transduction system. Adv Pharmacol 26, 19-33.
27. 2+-ATPase activity by calmidazolium. Pediatr Res 28, 46-49.
28. Pan BS & Johnson RG Jr (1996). Interaction of cardiotonic thiadiazinone derivatives with cardiac troponin C. J Biol Chem 271, 817-823.
29. Paolocci N, Ekelund UEG, Isoda T, Ozaki M, Vandegaer K, Georgakopoulos D, Harrison R, Kass DA & Hare MJ (2000). Cyclic nucleotide independent positive inotropic effects of nitric oxide donors: Potential role for nitrosylation. Am J Physiol Heart Circ Physiol 279, H1982-H1988.
30. Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ & Fukuto JM (2006). The pharmacology of nitroxyl (HNO) and its therapeutic potential: Not just the Janus face of NO. Pharmacol Ther 113, 442-458.
31. Paolocci N, Katori T, Champion HC, St John ME, Miranda KM, Fukuto JM, Wink DA & Kass DA (2003). Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: Independence from beta-adrenergic signaling. Proc Natl Acad Sci U S A 100, 5537-5542.
32. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA & Kass DA (2001). Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A 98, 10463-10468.
33. 2+-sensitizing property of xanthine oxidase inhibitors. Circ Res 83, 423-430.
34. Preckel B, Kojda G, Schlack W, Ebel D, Kottenberg K, Noack E & Thamer V (1997). Inotropic effects of glyceryl trinitrate and spontaneous NO donors in the dog heart. Circulation 96, 2675-2682.
35. 2+ sensitivity of rat myofibrils. J Biol Chem 272, 26887-26892.
36. Saavedra WF, Paolocci N, Zeichner J, Mudrick D, Marban E, Kass DA & Hare JM (2002). Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underling mechanoenergetic uncoupling in the failing heart. Circ Res 90, 297-304.
37. Saleem M & Ohshima H (2004). Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme. Biochem Biophys Res Commun 315, 455-462.
38. Sarkar D, Vallance P, Amirmansour C & Harding SE (2000). Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides. Cardiovasc Res 48, 430-439.
39. Sears CE, Ashley EA & Casadei B (2004). Nitric oxide control of cardiac function: Is neuronal nitric oxide synthase a key component? Philos Trans R Soc Lond B Biol Sci 359, 1021-1044.
40. Senzaki H, Isoda T, Paolocci N, Ekelund U, Hare JM & Kass DA (2000). Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033. Circulation 101, 1040-1048.
41. Slinker BK, Green HW 3rd, Wu Y, Kirkpatrick RD & Campbell KB (1997). Relaxation effect of CGP-48506, EMD-57033, and dobutamine in ejecting and isovolumically beating rabbit hearts. Am J Physiol Heart Circ Physiol 273, H2708-H2720.
42. Soergal DG, Georgakopoulos D, Stull LB, Kass DA & Murphy AM (2004). Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponim I truncation. Am J Physiol 286, H1785-H1792.
43. Szilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, Borbely A, Edes I & Papp Z (2005). Two inotropes with different mechanisms of action: Contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol 46, 369-376.
44. 2+ cycling. Circ Res 100, 96-104.
45. Weyrich AS, Ma XL, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ & Vinten-Johansen J (1994). Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 75, 692-700.
46. Wink DA, Miranda KM, Katori T, Mancardi D, Thomas DD, Ridnour L, Espey MG, Feelisch M, Colton CA, Fukuto JM, Pagliaro P, Kass DA & Paolocci N (2003). Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: A novel redox paradigm. Am J Physiol Heart Circ Physiol 285, H2264-H2276.
47. Yokoshiki H & Sperelakis N (2003). Vasodilating mechanisms of levosimendan. Cardiovasc Drugs Ther 17, 111-113.